Pipeline
A scalable pipeline of precision therapeutics for acute illness
Every product in our pipeline follows the same discipline: use our platform to identify the patients most likely to benefit from a therapy, develop the AI-Biomarker that finds them, validate the pairing in a clinical trial, and deliver the treatment to the right patients.
It’s a pipeline built for efficient scalability, turning existing and previously unsuccessful therapies into precision treatments for the conditions that need them most.
Steroids Companion Diagnostic
A diagnostic device that provides rapid turnaround measurements of an AI-Biomarker to guide treatment. It utilizes patient clinical data extracted from the EHR system – including vital, routine lab results, and demographic information – as inputs, along with concentrations of novel protein biomarkers assayed from plasma or whole blood.
Novel Drugs
Many therapies that failed in previous clinical trials targeted broad populations, making response to the drug difficult to discern. The trials simply couldn’t find the patients who should have been targeted for treatment based on their biology.
Our AI-Biomarkers are built to identify those patients, turning repurposed and previously unsuccessful drugs into new precision therapeutics.
nbsp;
The first novel therapeutics in our pipeline include:
Hyperinflammation drug
Coagulation drug
Immunosuppression drug
